Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SLNOW - Soleno Therapeutics Inc Warrant 2014-12.11.19 on Soleno Therapeutics Series A

Previous close
0.0354
0.035   100.000%

Share volume: 0
Last Updated: Fri 08 Nov 2019 10:00:01 PM CET
Medical Specialties: 0%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
52%
Profitability 60%
Dept financing 0%
Liquidity 0%
Performance 70%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.04
P/E Ratio 
N/A
DAY RANGE
$0.04 - $0.04
EPS 
$0.00
52 WEEK RANGE
$0.03 - $1.80
52 WEEK CHANGE
-$9.09
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,260
AVERAGE 30 VOLUME 
$1,241
Company detail
CEO: Anish Bhatnagar
Region: US
Website: http://www.soleno.life
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Recent news